Concurrent use of two long-acting injectable (LAI) antipsychotics in forensic patients with treatment-resistant schizophrenia: A case series. (PubMed, Australas Psychiatry) - Oct 1, 2026 - "Most frequent combination was olanzapine pamoate and zuclopenthixol decanoate and DDD median was 2.17 (range 0.48-10.13). Enhanced side-effect monitoring and multidisciplinary oversight are required when used. Data interpretation was limited by observational design, concomitant medications, and absence of standardized symptom measures."
Journal • CNS Disorders • Psychiatry • Schizophrenia
|
|
Asiri Rodrigo; Daveena Mawren; Jacques Claassen
|